Siemens Healthineers AG (CHIX:SHLD) Return-on-Tangible-Asset: 12.50% (As of Jun. 2026) — 12% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:SHLD Siemens Healthineers AG CHIX:SHLD
81 GF Score
Price €39.08
GF Value €51.60
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Siemens Healthineers AG Return-on-Tangible-Asset?

Siemens Healthineers AG CHIX:SHLD 81 Return-on-Tangible-Asset is 12.50% as of Jun. 2026, which is 12% above its 10-year median of 11.20. GuruFocus rates CHIX:SHLD with a GF Score™ of 81/100 and a GF Value™ of €51.60 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Siemens Healthineers AG ranks better than 84.66% on this metric.

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Siemens Healthineers AG's annualized Net Income for the quarter that ended in Jun. 2026 was €2,676 Mil. Siemens Healthineers AG's average total tangible assets for the quarter that ended in Jun. 2026 was €21,415 Mil. Therefore, Siemens Healthineers AG's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 was 12.50%.

The historical rank and industry rank for Siemens Healthineers AG's Return-on-Tangible-Asset or its related term are showing as below:

CHIX:SHLd' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 7.16   Med: 11.2   Max: 14.73
Current: 10.52

During the past 11 years, Siemens Healthineers AG's highest Return-on-Tangible-Asset was 14.73%. The lowest was 7.16%. And the median was 11.20%.

CHIX:SHLd's Return-on-Tangible-Asset is ranked better than
84.66% of 854 companies
in the Medical Devices & Instruments industry
Industry Median: 0.59 vs CHIX:SHLd: 10.52

Siemens Healthineers AG  (CHIX:SHLd) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Siemens Healthineers AG Return-on-Tangible-Asset Related Terms


Siemens Healthineers AG Return-on-Tangible-Asset Historical Data

* Premium members only.

The historical data trend for Siemens Healthineers AG's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Siemens Healthineers AG Return-on-Tangible-Asset Chart

Siemens Healthineers AG Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.29 10.81 7.16 9.21 10.19

Siemens Healthineers AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.38 11.32 8.66 9.70 12.50

CHIX:SHLD vs ABT, SYK, MDT: Return-on-Tangible-Asset Comparison

For the Medical Devices subindustry, Siemens Healthineers AG's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Siemens Healthineers AG Return-on-Tangible-Asset vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Siemens Healthineers AG's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Siemens Healthineers AG's Return-on-Tangible-Asset falls into.


CHIX:SHLD
81GF Score
Siemens Healthineers AG CHIX:SHLD
Return-on-Tangible-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Siemens Healthineers AG Return-on-Tangible-Asset Calculation

Siemens Healthineers AG's annualized Return-on-Tangible-Asset for the fiscal year that ended in Sep. 2025 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Sep. 2025 )  (A: Sep. 2024 )(A: Sep. 2025 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Sep. 2025 )  (A: Sep. 2024 )(A: Sep. 2025 )
=2144/( (21331+20740)/ 2 )
=2144/21035.5
=10.19 %

Siemens Healthineers AG's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=2676/( (20993+21837)/ 2 )
=2676/21415
=12.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Jun. 2026) net income data.

What does a Return-on-Tangible-Asset of 12.50% mean?
Siemens Healthineers AG (CHIX:SHLD) has a Return-on-Tangible-Asset of 12.50% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Siemens Healthineers AG and its competitors. This is 12% above median its historical median of 11.20. Over the past decade, Siemens Healthineers AG's Return-on-Tangible-Asset has ranged from 7.16 to 14.73. According to the industry distribution chart, Siemens Healthineers AG ranks #131 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 15.3%.
Is Siemens Healthineers AG's Return-on-Tangible-Asset too high?
Siemens Healthineers AG's current Return-on-Tangible-Asset of 12.50% is 12% above median its 10-year median of 11.20. Over the past 10 years, this metric has ranged from a low of 7.16 to a high of 14.73. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.59. Siemens Healthineers AG's value of 12.50% is 2018.6% above this industry median. Based on the distribution chart, Siemens Healthineers AG ranks #131 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Siemens Healthineers AG has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Siemens Healthineers AG's Return-on-Tangible-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Siemens Healthineers AG ranks #131 out of 854 companies for Return-on-Tangible-Asset. This places Siemens Healthineers AG in the top 15% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 0.59. Siemens Healthineers AG's value of 12.50% is 2018.6% above this benchmark. Historically, Siemens Healthineers AG's own Return-on-Tangible-Asset has ranged from 7.16 to 14.73 over the past decade. While the company's 10-year median is 11.20 vs. the industry median of 0.59, Siemens Healthineers AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.59, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Siemens Healthineers AG's current Return-on-Tangible-Asset of 12.50% is 2018.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Siemens Healthineers AG and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Siemens Healthineers AG's current Return-on-Tangible-Asset is 12.50%, which is 12% above median its own 10-year median of 11.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siemens Healthineers AG stock overvalued right now?
Based on GuruFocus' analysis, Siemens Healthineers AG (CHIX:SHLD) is currently considered Modestly Undervalued. The stock's GF Value™ is €51.60, compared to a current price of €39.08 — trading 24.3% below its estimated fair value. The current Return-on-Tangible-Asset is 12.50%, which is 12% above median its 10-year median of 11.20 and 2018.6% above the Medical Devices & Instruments industry median of 0.59. Siemens Healthineers AG's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Siemens Healthineers AG (CHIX:SHLD), the current Return-on-Tangible-Asset is 12.50% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Siemens Healthineers AG (CHIX:SHLD) Overvalued in 2026?

Based on GuruFocus' analysis, Siemens Healthineers AG stock appears to be undervalued. The current stock price of €39.08 is trading 24.3% below its estimated GF Value™ of €51.60. GuruFocus considers Siemens Healthineers AG to be Modestly Undervalued.

Key valuation signals for CHIX:SHLD:

  • Return-on-Tangible-Asset: 12.50% (12% above median its 10-year median of 11.20)
  • GF Value™: €51.60 vs. price of €39.08 (24.3% below fair value)
  • GF Score™: 81/100 with 4 warning signs
  • Industry Position: 2018.6% above the Medical Devices & Instruments median (#131 of 854)

No single metric tells the full story. See the CHIX:SHLD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Siemens Healthineers AG Business Description

Address Siemensstrasse 3, Forchheim, BY, DEU, 91301
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.
81GF Score

Get the complete analysis for CHIX:SHLD

Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€39.08
Price
€51.60
GF Value